Validity Reliability of The Dubousset Functional Test in Older Adults

January 20, 2022 updated by: Ayşe Abit Kocaman, Kırıkkale University

Postural deformity and postural instability that occur with aging are risk factors for falling.

In the literature, there are many scales that evaluate balance and functional performance in older adults. However there is no validity and reliability study of Dubousset Function Test developed to evaluate balance and functional performance of older adults. For this reason, the aim of study is to examine the validity and reliability of Dubousset Function Test in older adults.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

However, postural deformity and postural instability that occur with aging are risk factors for falling. In studies examining the relationship between postural instability and spinal curvatures, it was stated that the balance and functional performance of patients with increased kyphosis were affected. Increased thoracic kyphosis and lumbar lordosis loss in geriatric individuals, degenerative spinal deformities are common and functional limitations lead to negative clinical consequences such as an increase in the risk of falls or fractures and impaired quality of life.

Dubousset Functional Test (DFT); A conceptually practical four-component assessment test has been proposed by Dr. Jean Dubousset to assess the functional capacity of adult individuals. The validity of the test was made in individuals with spinal deformity. DFT; It consists of four components: getting up from a chair without arms and walking 5 meters forward and backward, descending and climbing steps, transition from standing to sitting on the ground, and the dual task test in which the individual walks while counting down from 50 at the same time.

In the literature, there are many scales that evaluate balance and functional performance in elderly individuals.However, there is no validity and reliability study of Dubousset Function Test developed to evaluate balance and functional performance of adult individuals in elderly individuals. For this reason, the aim of study is to examine the validity and reliability of Dubousset Function Test in older adults.

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kırıkkale, Turkey, 7110
        • Kırıkkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals aged 65 and over, Volunteering to participate in research, No cooperation and communication problem

Description

Inclusion Criteria:

  • Individuals aged 65 and over,
  • Volunteering to participate in research
  • No cooperation and communication problem

Exclusion Criteria:

  • Individuals with neurological and orthopedic problems
  • Uncontrollable hypertension
  • Those with cardiac disease
  • Those with cooperation and communication problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
older adults, assessment
Dubousset Function Test, 3-m backwards walk test, timed up and go test,Tinnetti Balance and Gait Test, Berg BalanceTest, Functional Reach Test

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dubousset Function Test
Time Frame: first day
The four components of the DFT included (1) the Up Walking Test: participants rose without assistance from a and seated position in a chair that did not have arms, walked 5 meters (500 cm) forward before stopping, walked backwards 5 meters, and sat again without assistance; (2) the Steps Test: from a starting position 50 cm away, volunteers climbed three stairs, turned around on the third step (top), and walked down the three steps; (3) Down and Sitting Test: from a standing position, participants sat on the ground and stood up again, using assistance as needed; (4) Dual-Tasking Test: participants walked 5 meters forward, turned around, and walked 5 meters back to the starting position while performing a working memory test (counting down from 50 by intervals of 2).
first day
timed up and go test
Time Frame: first day
A standard chair is used for testing. First, the patient is asked to sit on the chair. The patient is then asked to stand up and walk regularly at a distance of 3 meters with a predetermined length, then return to the chair after 3 meters.
first day
3-m backwards walk test,
Time Frame: first day

A distance of 3 m is measured and marked with black tape. Individuals are asked to follow the heel and black band.

With the 'start' command they are asked to walk backwards quickly. When the distance of 3 m is completed, a stop is instructed. Individuals are not allowed to run during the test. They are allowed to look back if they wish. The assessor walks behind individuals throughout the test. The test is repeated 3 times, the averages are recorded

first day
Tinetti Balance and Gait Test
Time Frame: first day
In the test used to evaluate balance, walking score is maximum 12 points, balance score is maximum 16 points and a total of 28 points.
first day
Berg Balance Test
Time Frame: first day
The BBS consists of 14 items to directly monitor the maintenance of body balance during performance
first day
Funtional Reach Test
Time Frame: first day
It is used to measure both the balance of the individual functionally and the amount of dynamic reach
first day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 15, 2020

Primary Completion (ACTUAL)

January 1, 2022

Study Completion (ACTUAL)

January 15, 2022

Study Registration Dates

First Submitted

October 9, 2020

First Submitted That Met QC Criteria

October 19, 2020

First Posted (ACTUAL)

October 20, 2020

Study Record Updates

Last Update Posted (ACTUAL)

January 21, 2022

Last Update Submitted That Met QC Criteria

January 20, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • The Dubousset Functional Test

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on older adults, assessment

Subscribe